A comparative study of the effect of proton pump inhibitor and ranitidine on serum magnesium level and blood pressure in chronic hemodialysis patients with hypotentio

Not Applicable

Recruiting

• Conditions: Renal failure.; End stage renal disease; N18.6

• Registration Number: IRCT20150808023559N19
• Lead Sponsor: Vice chancellor for research, Ardabil University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 December 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

ESRD patients with hypotension during dialysis

Exclusion Criteria

Serum Magnesium below 2
Antihypertensive therapy
cancer
Severe Congestive Heart Failure

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hypotension. Timepoint: Before starting the Hemodialysis and every 60 minutes during Hemodialysis. Method of measurement: Mercury barometer.

Secondary Outcome Measures

Name	Time	Method
Hypomagnesiumia. Timepoint: Before and after intervention. Method of measurement: Lab.